The Rise of Badger Meter Inc. Beyond Analyst Expectations

Avatar photo

Analyst Reactions: A Balancing Act

In recent trading, shares of Badger Meter Inc (Symbol: BMI) have soared above the average analyst 12-month target price of $152.80, settling at $153.84/share. When a stock hits the target set by an analyst, their response generally hinges on two options: downgrade due to valuation concerns or readjust the target upward. Analyst sentiment may also sway based on underlying business drivers propelling the stock price skyward. If the company’s outlook appears bright, it may well be time for an upward revision of that target.

There exist 5 distinct analyst targets within the Zacks coverage universe that feed into the average for Badger Meter Inc. However, remember, an average is simply that – a numerical average. Deviations from this mean are prevalent, with one analyst eyeing a $120.00 price, while another sets their target at a lofty $190.00. The standard deviation stands at $25.033.

Yet, the intent of scrutinizing the average BMI target price is to tap into the ‘wisdom of crowds’ concept. It amalgamates the insights of multiple minds contributing to the final figure, rather than relying on the opinion of a sole expert. Therefore, with BMI surpassing the average target price of $152.80/share, investors are handed a valuable cue to reassess the company themselves. The pivotal question emerges: is $152.80 merely a stepping stone to an even greater target, or has the valuation stretched so thin that it’s prudent to consider cashing in some gains? Below is a snapshot illustrating the current sentiments of analysts covering Badger Meter Inc.

Recent BMI Analyst Ratings Breakdown
» Current 1 Month Ago 2 Month Ago 3 Month Ago
Strong buy ratings: 2 2 2 2
Buy ratings: 0 0 0 0
Hold ratings: 3 3 3 3
Sell ratings: 0 0 0 0
Strong sell ratings: 1 1 1 1
Average rating: 2.67 2.67 2.67 2.67

The average rating shown in the final row of the table falls between 1 and 5 – a scale where 1 translates to Strong Buy and 5 signifies Strong Sell. This article draws data from Zacks Investment Research via Quandl.com. Access the most recent Zacks research report on BMI — FREE.

Explore 10 ETFs With Most Upside To Analyst Targets »

Related Insights:

• Dive into the Institutional Holders of ELCO
• Track MRK’s Year-To-Date Return
• Witness AMLP’s Year-To-Date Performance

The thoughts and viewpoints conveyed in this piece represent the author’s perspective and do not necessarily mirror those of Nasdaq, Inc.

5 Stocks Our Experts Predict Could Double In the Next Year

By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.

The free Daily Market Overview 250k traders and investors are reading

Read Now